Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes
Glucagon-like peptide-1 (GLP-1) regulates processes involved in the pathophysiology of thoracic aortic aneurysms (TAAs), including inflammation, while protecting against aortic aneurysms in animal models. Type 2 diabetes (T2D) involves altered GLP-1 signaling due to pathology and/or therapy and is a...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8db087a40f341e28b618294f0b321a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c8db087a40f341e28b618294f0b321a1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c8db087a40f341e28b618294f0b321a12021-11-25T18:00:17ZElevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes10.3390/jcdd81101432308-3425https://doaj.org/article/c8db087a40f341e28b618294f0b321a12021-10-01T00:00:00Zhttps://www.mdpi.com/2308-3425/8/11/143https://doaj.org/toc/2308-3425Glucagon-like peptide-1 (GLP-1) regulates processes involved in the pathophysiology of thoracic aortic aneurysms (TAAs), including inflammation, while protecting against aortic aneurysms in animal models. Type 2 diabetes (T2D) involves altered GLP-1 signaling due to pathology and/or therapy and is associated with reduced prevalence of TAAs. We aimed to assess whether T2D alters the inflammatory profile/proteolytic activity, possible correlations to elevated fasting GLP-1 (F-GLP-1), and its relevance for TAA. F-GLP-1, pro-inflammatory T helper 1 (Th1) cytokines, Th2 cytokines, C-reactive protein, and matrix metalloproteinase-2 activity (MMP-2) were analyzed in surgical patients with aortic valve pathology with/without T2D and without T2D but with TAA. Patients with T2D displayed an increase in the relative systemic expression of interleukin 6 and tumor necrosis factor α and a clear trend towards reduced levels of interferon γ (IFNγ). In addition, a positive association between GLP-1 and the plasma interleukin 4 (IL-4)/IFNγ ratio was detected. TAA was associated with significantly lower plasma levels of the Th2 cytokines IL-4 and interleukin 5. Plasma MMP-2 activity did not differ between groups. We conclude that T2D involved a Th2 shift, which associates with elevated F-GLP-1 and may—considering Th1 bias in TAA—contribute to reduced prevalence of TAA in T2D.Stelia NtikaHarshitha JoisKarin LångChristian OlssonAnders Franco-CerecedaHanna M. BjörckCamilla KrizhanovskiiMDPI AGarticleaneurysmtype 2 diabetesglucagon-like peptide-1inflammationcytokinesDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of Cardiovascular Development and Disease, Vol 8, Iss 143, p 143 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
aneurysm type 2 diabetes glucagon-like peptide-1 inflammation cytokines Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
aneurysm type 2 diabetes glucagon-like peptide-1 inflammation cytokines Diseases of the circulatory (Cardiovascular) system RC666-701 Stelia Ntika Harshitha Jois Karin Lång Christian Olsson Anders Franco-Cereceda Hanna M. Björck Camilla Krizhanovskii Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes |
description |
Glucagon-like peptide-1 (GLP-1) regulates processes involved in the pathophysiology of thoracic aortic aneurysms (TAAs), including inflammation, while protecting against aortic aneurysms in animal models. Type 2 diabetes (T2D) involves altered GLP-1 signaling due to pathology and/or therapy and is associated with reduced prevalence of TAAs. We aimed to assess whether T2D alters the inflammatory profile/proteolytic activity, possible correlations to elevated fasting GLP-1 (F-GLP-1), and its relevance for TAA. F-GLP-1, pro-inflammatory T helper 1 (Th1) cytokines, Th2 cytokines, C-reactive protein, and matrix metalloproteinase-2 activity (MMP-2) were analyzed in surgical patients with aortic valve pathology with/without T2D and without T2D but with TAA. Patients with T2D displayed an increase in the relative systemic expression of interleukin 6 and tumor necrosis factor α and a clear trend towards reduced levels of interferon γ (IFNγ). In addition, a positive association between GLP-1 and the plasma interleukin 4 (IL-4)/IFNγ ratio was detected. TAA was associated with significantly lower plasma levels of the Th2 cytokines IL-4 and interleukin 5. Plasma MMP-2 activity did not differ between groups. We conclude that T2D involved a Th2 shift, which associates with elevated F-GLP-1 and may—considering Th1 bias in TAA—contribute to reduced prevalence of TAA in T2D. |
format |
article |
author |
Stelia Ntika Harshitha Jois Karin Lång Christian Olsson Anders Franco-Cereceda Hanna M. Björck Camilla Krizhanovskii |
author_facet |
Stelia Ntika Harshitha Jois Karin Lång Christian Olsson Anders Franco-Cereceda Hanna M. Björck Camilla Krizhanovskii |
author_sort |
Stelia Ntika |
title |
Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes |
title_short |
Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes |
title_full |
Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes |
title_fullStr |
Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes |
title_full_unstemmed |
Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes |
title_sort |
elevated glucagon-like peptide-1 and a th2 shift may support reduced prevalence of thoracic aortic aneurysm in patients with diabetes |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/c8db087a40f341e28b618294f0b321a1 |
work_keys_str_mv |
AT steliantika elevatedglucagonlikepeptide1andath2shiftmaysupportreducedprevalenceofthoracicaorticaneurysminpatientswithdiabetes AT harshithajois elevatedglucagonlikepeptide1andath2shiftmaysupportreducedprevalenceofthoracicaorticaneurysminpatientswithdiabetes AT karinlang elevatedglucagonlikepeptide1andath2shiftmaysupportreducedprevalenceofthoracicaorticaneurysminpatientswithdiabetes AT christianolsson elevatedglucagonlikepeptide1andath2shiftmaysupportreducedprevalenceofthoracicaorticaneurysminpatientswithdiabetes AT andersfrancocereceda elevatedglucagonlikepeptide1andath2shiftmaysupportreducedprevalenceofthoracicaorticaneurysminpatientswithdiabetes AT hannambjorck elevatedglucagonlikepeptide1andath2shiftmaysupportreducedprevalenceofthoracicaorticaneurysminpatientswithdiabetes AT camillakrizhanovskii elevatedglucagonlikepeptide1andath2shiftmaysupportreducedprevalenceofthoracicaorticaneurysminpatientswithdiabetes |
_version_ |
1718411769484935168 |